Axsome Therapeutics
(NASDAQ) AXSM
Axsome Therapeutics Financials at a Glance
Market Cap
$8.40B
Revenue (TTM)
$638.50M
Net Income (TTM)
$183.17M
EPS (TTM)
$-3.69
P/E Ratio
-44.47
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$156.37
Volume
20,871
Open
$164.49
Price
$156.37
Volume
20,871
Open
$164.49
Previous Close
$156.37
Daily Range
$155.81 - $164.49
52-Week Range
$86.99 - $191.50
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$156.37
Volume
20,871
Open
$164.49
Previous Close
$156.37
Daily Range
$155.81 - $164.49
52-Week Range
$86.99 - $191.50
AXSM News
AXSM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Axsome Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
925
CEO
Herriott Tabuteau, MD
Website
www.axsome.comHeadquarters
New York City, NY 10007, US
AXSM Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-27%
Net Income Margin
-29%
Return on Equity
-252%
Return on Capital
-54%
Return on Assets
-27%
Earnings Yield
-2.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.40B
Shares Outstanding
51.15M
Volume
20.87K
Short Interest
0.00%
Avg. Volume
690.81K
Financials (TTM)
Gross Profit
$591.02M
Operating Income
$169.24M
EBITDA
$168.08M
Operating Cash Flow
$93.41M
Capital Expenditure
$0.00
Free Cash Flow
$93.41M
Cash & ST Invst.
$322.93M
Total Debt
$241.29M
Axsome Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$196.00M
+65.0%
Gross Profit
$183.67M
+69.7%
Gross Margin
93.71%
N/A
Market Cap
$8.40B
N/A
Market Cap/Employee
$11.80M
N/A
Employees
712
N/A
Net Income
$28.56M
+61.9%
EBITDA
$24.68M
+65.0%
Quarterly Fundamentals
Net Cash
$81.64M
-33.3%
Accounts Receivable
$224.46M
+58.1%
Inventory
$27.94M
+77.6%
Long Term Debt
$168.32M
-11.3%
Short Term Debt
$72.98M
+2141.4%
Return on Assets
-26.55%
N/A
Return on Invested Capital
-54.42%
N/A
Free Cash Flow
$19.00M
+27.6%
Operating Cash Flow
$18.65M
+28.8%